A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer
This study has been withdrawn prior to enrollment.
First Posted: September 14, 2012
Last Update Posted: October 27, 2015
University of Washington
Fred Hutchinson Cancer Research Center
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|